Don Gregory Neeb - 01 Aug 2025 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Reporting relationship: EVP, Chief Invest & Strategy
Issuer ticker: MD
Reported as of: 01 Aug 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Aug 2025, 17:05:04 UTC
Next SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Mary Ann E. Moore, Attorney-in-Fact

Key filing fact

Don Gregory Neeb filed Form 4 for Pediatrix Medical Group, Inc. (MD) on 05 Aug 2025.

Key facts

This page summarizes Don Gregory Neeb's Form 4 filing for Pediatrix Medical Group, Inc. (MD).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Aug 2025, 17:05.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002079487 Primary reporting owner

Neeb Don Gregory

Relationship: EVP, Chief Invest & Strategy
Address: 1301 CONCORD TERRACE, SUNRISE
Signature: /s/ Mary Ann E. Moore, Attorney-in-Fact
Signature date: 05 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MD transaction

Common Stock

Award

Transaction value: $0
Shares: +81,346
Change %
Price: $0.000000
Shares after: 81,346
Date: 01 Aug 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MD transaction Derivative

Performance Share Unit

Award

Transaction value: $0
Shares: +320,000
Change %
Price: $0.000000
Shares after: 320,000
Date: 01 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 320,000
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2026, twenty-five percent (25%) of the restricted shares will vest on June 1, 2027 and fifty percent (50%) of the restricted shares will vest on June 1, 2028, subject to the terms of the Plan.

Footnote F2

Each Performance Share Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. The PSUs vest upon the satisfaction of both the service-based condition and a performance-based condition. The PSUs will vest, to the extent earned, on the three-year anniversary of the grant date, with the shares underlying the PSUs being earned in one-third installments based on the Issuer achieving stock price hurdles equal to $16.94, $20.33 and $23.71 for at least 20 consecutive trading days before the third anniversary of the grant date.